Swiss Software Stock News

Novartis (SWX:NOVN) is back in focus after new clinical data showed its radioligand therapy Pluvicto, when added to standard treatment, cut the risk of PSA progression by 58% in a specific prostate cancer setting. See our latest analysis for Novartis. Alongside the Pluvicto data and a series of US manufacturing and research expansions, Novartis has seen firm investor interest, with the share price at CHF117.2 and an 8.02% year to date share price return, while the 1 year total shareholder...

Investors may be asking whether Swisscom at CHF676.0 is offering fair value right now, or if the recent momentum has already priced in the opportunity. The stock has returned 1.0% over the past week, 3.9% over the past month, 16.8% year to date, and 27.2% over the last year, which naturally raises questions about how much of its potential is already reflected in the price. Recent attention on Swisscom has focused on its role as a major Swiss telecom operator and how investors view its...

In early May 2026, Novartis broke ground on a new 46,000 sq. ft radioligand therapy manufacturing facility in Denton, Texas, part of its US$23.00 billion US manufacturing and research expansion and its fifth radioligand therapy site nationwide. This build-out of a coast-to-coast radioligand therapy network highlights how Novartis is tying manufacturing proximity and reliability directly to complex cancer treatment delivery for US patients. We will now explore how this expanded US radioligand...

Temenos (SWX:TEMN) is back in focus after a cluster of fresh contracts and product launches, including new core banking deals with Habib Bank Limited and Reliance Bank, as well as extended collaborations with First Abu Dhabi Bank and Questrade Financial Group. See our latest analysis for Temenos. The recent stream of banking deals and AI product launches comes against a mixed backdrop. The share price stands at CHF71.45, with a 90 day share price return of 11.29%, but a year to date share...

Adecco Group (SWX:ADEN) opened 2026 with Q1 revenue of €5.7b and basic EPS of €0.41, setting a clear benchmark for how the year is starting after a steady run of quarterly results. The company has seen revenue move from €5.6b in Q1 2025 to €5.7b in Q1 2026, while basic EPS over that same period went from €0.36 to €0.41. Trailing twelve month EPS of €1.81 provides a broader earnings backdrop. With net income of €69m in the quarter and a net profit margin of 1.3%, the story now is how...

Akkodis, a subsidiary of Adecco Group (SWX:ADEN), has been recognized as an Enterprise Innovator for its agentic AI capabilities. The recognition highlights Akkodis' progress in practical AI deployment and Services-as-Software transformation across enterprise clients. The assessment emphasizes strengths in scalable AI execution and data governance, pointing to operational impact beyond financial metrics. Adecco Group, through Akkodis, is leaning into AI driven services at a time when large...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

PSP Swiss Property (SWX:PSPN) has opened Q1 2026 earnings season with trailing 12 month revenue of CHF 351.05 million and Basic EPS of CHF 8.91, backed by an 8.9% year over year improvement in earnings and supported by a one off gain of CHF 238.8 million that lifted reported profit. Over recent quarters, revenue has held in a tight band between CHF 87.44 million and CHF 88.65 million per quarter, while quarterly Basic EPS has ranged from CHF 1.32 to CHF 3.25. This has fed into that CHF 8.91...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Q1 earnings set the tone for Swiss Re stock Swiss Re (SWX:SREN) put its first quarter on the table on May 7, reporting net income of US$1,506 million versus US$1,267 million a year earlier, alongside its Q1 2026 earnings call. See our latest analysis for Swiss Re. Despite the stronger Q1 net income, the stock has come under pressure, with the share price down 10.6% over the past month and the 1 year total shareholder return declining 14.08%, although the 5 year total shareholder return of...

Earlier this week, Sensirion Holding reported revenue growth of 18.58% alongside a zero-debt balance sheet and solid liquidity, reinforcing its financial strength. This combination of accelerating top-line performance and a clean capital structure adds an extra layer of resilience to Sensirion’s existing growth story. Next, we’ll examine how this strong revenue momentum and debt-free position may reshape Sensirion Holding’s existing investment narrative. Capitalize on the AI...

Swiss Re AG ( VTX:SREN ) last week reported its latest first-quarter results, which makes it a good time for investors...

The European stock market recently experienced a volatile week, with modest gains in the pan-European STOXX Europe 600 Index, as investor sentiment was buoyed by easing geopolitical tensions and strong corporate earnings. However, looming threats of increased tariffs from the U.S. added pressure to markets. In this context, identifying undervalued stocks becomes crucial for investors seeking opportunities that are potentially trading below their intrinsic value amidst fluctuating market...

Valiant Holding AG reported first-quarter 2026 results with net interest income of CHF 100.64 million and net income of CHF 33.24 million, both slightly higher than a year earlier. Despite this modest improvement, investors focused on the bank’s challenging revenue trends. We’ll now examine how these weaker-than-expected earnings in the context of the bank's valuation estimates.

Why Kuros Biosciences (SWX:KURN) is on investors’ radar today Kuros Biosciences (SWX:KURN) has drawn attention after recent share price pressure, with the stock showing a 15.1% decline over the past month and a 20.2% decline over the past 3 months. See our latest analysis for Kuros Biosciences. At the latest share price of CHF20.12, Kuros Biosciences shows weaker short term momentum, with a 1 month share price return of 15.1% decline and a year to date share price return of 24.6% decline,...

If you are asking whether UBS Group is priced attractively right now, the starting point is to look closely at what the current share price might already be assuming. The stock last closed at CHF 35.03, with returns of 1.5% over 7 days, 8.1% over 30 days, a 8.2% decline year to date, and gains of 38.4% over 1 year, 120.8% over 3 years and 189.1% over 5 years. Recent headlines have focused on UBS Group's role as a major global banking and wealth management group, including its ongoing...

If you are wondering whether Temenos is priced fairly or if the current share price leaves room for upside, it helps to start by looking closely at what the market has been paying for this stock recently. Temenos shares recently closed at CHF 74.20, with returns of 0.4% over 7 days, 2.3% over 30 days, a 9.0% decline year to date, and 22.6% over the past year. Together, these figures present a mixed picture of changing expectations and risk perception. Recent coverage of Temenos has focused...

The investors in ams-OSRAM AG 's ( VTX:AMS ) will be rubbing their hands together with glee today, after the share...

UBS Group is signaling interest in expanding in the US through acquisitions following its integration of Credit Suisse. Leadership is highlighting growth ambitions in the Americas and pointing to recent inflows of new client assets in the region. The group has received a national US banking license and announced executive hires in key US regions to support potential expansion. UBS Group (SWX:UBSG) is trading around CHF34.94, with the stock up 39.1% over the past year and 190.3% over five...

Investors in Logitech International S.A. ( VTX:LOGN ) had a good week, as its shares rose 6.6% to close at CHF81.82...

As you might know, Geberit AG ( VTX:GEBN ) recently reported its quarterly numbers. Geberit reported in line with...

Earnings miss, weaker profit, and new buyback sharpen focus on Alcon stock Alcon (SWX:ALC) reported first quarter 2026 revenue growth supported by recent product launches and market share gains. Profit came under pressure, guidance was reaffirmed, and a US$1.5b share repurchase plan was introduced. See our latest analysis for Alcon. Alcon's latest earnings and the new US$1.5b buyback have coincided with a sharp reset in sentiment, with a 7 day share price return of a 13.6% decline and a 1...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Sunrise Communications AG ( VTX:SUNN ) stock is about to trade ex-dividend in three days. The ex-dividend date is...